Reply from Authors re: Mark S. Soloway, Michael Garcia-Roig, Michael A. Gorin and Rajinikanth Ayyathurai. How can we improve outcomes for upper tract urothelial carcinoma? Eur Urol 2012;61:254-6

European Urology

Volumn 61, Issue 2, 2012, Pages 256-257

  Rink, Michael ^a,b   Cha, Eugene K ^b   Shariat, Shahrokh F ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; CYTOLOGY; FEMALE GENITAL TRACT CYTOLOGY; HIGH RISK PATIENT; HUMAN; HYDRONEPHROSIS; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; TRANSITIONAL CELL CARCINOMA; UPPER TRACT UROTHELIAL CARCINOMA; URETEROSCOPY;

EID: 83955165416     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.10.041     Document Type: Editorial

References (15)

1. M.S. Soloway, M. Garcia-Roig, M.A. Gorin, and R. Ayyathurai How can we improve outcomes for upper tract urothelial carcinoma? Eur Urol 61 2012 254 256
2. T.F. Chromecki, K. Bensalah, and M. Remzi Prognostic factors for upper urinary tract urothelial carcinoma Nat Rev Urol 8 2011 440 447
3. J.D. Raman, J. Messer, J.A. Sielatycki, and C.S. Hollenbeak Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005 BJU Int 107 2011 1059 1064
4. J.C. Brien, S.F. Shariat, and M.P. Herman Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma J Urol 184 2010 69 73
5. M. Remzi, A. Haitel, and V. Margulis Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients BJU Int 103 2009 307 311
6. C.K. Ng, S.F. Shariat, and S.M. Lucas Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol 29 2011 27 32
7. T.F. Chromecki, E.K. Cha, and H. Fajkovic The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy Eur Urol 61 2012 245 253
8. S.F. Matin, V. Margulis, and A. Kamat Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma Cancer 116 2010 3127 3134
9. M.Z. Rajput, A.M. Kamat, and J. Clavell-Hernandez Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy Urology 78 2011 61 67
10. M.G. Kaag, R.L. O'Malley, and P. O'Malley Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy Eur Urol 58 2010 581 587
11. N.J. Hellenthal, S.F. Shariat, and V. Margulis Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration J Urol 182 2009 900 906
12. V. Margulis, R.F. Youssef, and P.I. Karakiewicz Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract J Urol 184 2010 453 458
13. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
14. H. Fajkovic, J.A. Halpern, and E.K. Cha Impact of gender on bladder cancer incidence, staging, and prognosis World J Urol 29 2011 457 463
15. M. Rouprêt, R. Zigeuner, and J. Palou European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584 594